Method of inhibiting complement activation with human...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2681741

A method of inhibiting complement activation mediated by C3b inhibitors in a subject includes administering a C3B inhibitor to the subject to inhibit at least one of C3b binding to factors B and properdin, inhibit C3 cleavage, inhibit the activation of neutrophils, monocytes, platelets, and endothelium; or inhibit the formation of C3a, C5a, and MAC.

La présente invention concerne un procédé d'inhibition de l'activation du complément par des inhibiteurs du C3b chez un sujet, comprenant l'administration d'un inhibiteur du C3b au sujet pour inhiber au moins l'une des liaisons du C3b aux facteurs B et à la properdine, inhiber la coupure du C3, inhiber l'activation des neutrophiles, des monocytes, des plaquettes, et de l'endothélium; ou inhiber la formation du C3a, du C5a, et du MAC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of inhibiting complement activation with human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting complement activation with human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting complement activation with human... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1971992

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.